Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART‐REACH Model

BACKGROUND: In patients with vascular disease, risk models may support decision making on novel risk reducing interventions, such as proprotein convertase subtilisin/kexin type 9 inhibitors or anti‐inflammatory agents. We developed and validated an innovative model to estimate life expectancy withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaasenbrood, Lotte, Bhatt, Deepak L., Dorresteijn, Jannick A.N., Wilson, Peter W.F., D'Agostino, Ralph B., Massaro, Joseph M., van der Graaf, Yolanda, Cramer, Maarten J.M., Kappelle, L. Jaap, de Borst, Gert J., Steg, Ph. Gabriel, Visseren, Frank L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201391/
https://www.ncbi.nlm.nih.gov/pubmed/30369323
http://dx.doi.org/10.1161/JAHA.118.009217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201391/
https://www.ncbi.nlm.nih.gov/pubmed/30369323
http://dx.doi.org/10.1161/JAHA.118.009217

Ejemplares similares